Cargando…
Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study
BACKGROUND: Clinical trials with longitudinally measured outcomes are often plagued by missing data due to patients withdrawing or dropping out from the trial before completing the measurement schedule. The reasons for dropout are sometimes clearly known and recorded during the trial, but in many in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849065/ https://www.ncbi.nlm.nih.gov/pubmed/27125779 http://dx.doi.org/10.1186/s13063-016-1342-0 |
_version_ | 1782429481524264960 |
---|---|
author | Kolamunnage-Dona, Ruwanthi Powell, Colin Williamson, Paula Ruth |
author_facet | Kolamunnage-Dona, Ruwanthi Powell, Colin Williamson, Paula Ruth |
author_sort | Kolamunnage-Dona, Ruwanthi |
collection | PubMed |
description | BACKGROUND: Clinical trials with longitudinally measured outcomes are often plagued by missing data due to patients withdrawing or dropping out from the trial before completing the measurement schedule. The reasons for dropout are sometimes clearly known and recorded during the trial, but in many instances these reasons are unknown or unclear. Often such reasons for dropout are non-ignorable. However, the standard methods for analysing longitudinal outcome data assume that missingness is non-informative and ignore the reasons for dropout, which could result in a biased comparison between the treatment groups. METHODS: In this article, as a post hoc analysis, we explore the impact of informative dropout due to competing reasons on the evaluation of treatment effect in the MAGNETIC trial, the largest randomised placebo-controlled study to date comparing the addition of nebulised magnesium sulphate to standard treatment in acute severe asthma in children. We jointly model longitudinal outcome and informative dropout process to incorporate the information regarding the reasons for dropout by treatment group. RESULTS: The effect of nebulised magnesium sulphate compared with standard treatment is evaluated more accurately using a joint longitudinal-competing risk model by taking account of such complexities. The corresponding estimates indicate that the rate of dropout due to good prognosis is about twice as high in the magnesium group compared with standard treatment. CONCLUSIONS: We emphasise the importance of identifying reasons for dropout and undertaking an appropriate statistical analysis accounting for such dropout. The joint modelling approach accounting for competing reasons for dropout is proposed as a general approach for evaluating the sensitivity of conclusions to assumptions regarding missing data in clinical trials with longitudinal outcomes. TRIAL REGISTRATION: EudraCT number 2007-006227-12. Registration date 18 Mar 2008. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-016-1342-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4849065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48490652016-04-29 Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study Kolamunnage-Dona, Ruwanthi Powell, Colin Williamson, Paula Ruth Trials Research BACKGROUND: Clinical trials with longitudinally measured outcomes are often plagued by missing data due to patients withdrawing or dropping out from the trial before completing the measurement schedule. The reasons for dropout are sometimes clearly known and recorded during the trial, but in many instances these reasons are unknown or unclear. Often such reasons for dropout are non-ignorable. However, the standard methods for analysing longitudinal outcome data assume that missingness is non-informative and ignore the reasons for dropout, which could result in a biased comparison between the treatment groups. METHODS: In this article, as a post hoc analysis, we explore the impact of informative dropout due to competing reasons on the evaluation of treatment effect in the MAGNETIC trial, the largest randomised placebo-controlled study to date comparing the addition of nebulised magnesium sulphate to standard treatment in acute severe asthma in children. We jointly model longitudinal outcome and informative dropout process to incorporate the information regarding the reasons for dropout by treatment group. RESULTS: The effect of nebulised magnesium sulphate compared with standard treatment is evaluated more accurately using a joint longitudinal-competing risk model by taking account of such complexities. The corresponding estimates indicate that the rate of dropout due to good prognosis is about twice as high in the magnesium group compared with standard treatment. CONCLUSIONS: We emphasise the importance of identifying reasons for dropout and undertaking an appropriate statistical analysis accounting for such dropout. The joint modelling approach accounting for competing reasons for dropout is proposed as a general approach for evaluating the sensitivity of conclusions to assumptions regarding missing data in clinical trials with longitudinal outcomes. TRIAL REGISTRATION: EudraCT number 2007-006227-12. Registration date 18 Mar 2008. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-016-1342-0) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-28 /pmc/articles/PMC4849065/ /pubmed/27125779 http://dx.doi.org/10.1186/s13063-016-1342-0 Text en © Kolamunnage-Dona et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Kolamunnage-Dona, Ruwanthi Powell, Colin Williamson, Paula Ruth Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study |
title | Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study |
title_full | Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study |
title_fullStr | Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study |
title_full_unstemmed | Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study |
title_short | Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study |
title_sort | modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the magnetic study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849065/ https://www.ncbi.nlm.nih.gov/pubmed/27125779 http://dx.doi.org/10.1186/s13063-016-1342-0 |
work_keys_str_mv | AT kolamunnagedonaruwanthi modellingvariabledropoutinrandomisedcontrolledtrialswithlongitudinaloutcomesapplicationtothemagneticstudy AT powellcolin modellingvariabledropoutinrandomisedcontrolledtrialswithlongitudinaloutcomesapplicationtothemagneticstudy AT williamsonpaularuth modellingvariabledropoutinrandomisedcontrolledtrialswithlongitudinaloutcomesapplicationtothemagneticstudy |